Published in J Vis Exp on February 11, 2008
Logarithmic sensing in Escherichia coli bacterial chemotaxis. Biophys J (2009) 1.78
Different migration patterns of sea urchin and mouse sperm revealed by a microfluidic chemotaxis device. PLoS One (2013) 0.87
Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell (1992) 3.82
A hydrogel-based microfluidic device for the studies of directed cell migration. Lab Chip (2007) 2.34
Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc Natl Acad Sci U S A (1997) 2.20
Expression of a naturally occurring constitutively active variant of the epidermal growth factor receptor in mouse fibroblasts increases motility. Int J Cancer (2004) 1.28
Repellents for Escherichia coli operate neither by changing membrane fluidity nor by being sensed by periplasmic receptors during chemotaxis. J Bacteriol (1990) 1.01
The duality of epidermal growth factor receptor (EGFR) signaling and neural stem cell phenotype: cell enhancer or cell transformer? Curr Stem Cell Res Ther (2006) 0.91
A hydrogel-based microfluidic device for the studies of directed cell migration. Lab Chip (2007) 2.34
Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis. J Neurosurg (2012) 2.29
Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases. J Neurosurg (2014) 2.03
A three-channel microfluidic device for generating static linear gradients and its application to the quantitative analysis of bacterial chemotaxis. Lab Chip (2005) 1.85
Logarithmic sensing in Escherichia coli bacterial chemotaxis. Biophys J (2009) 1.78
Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival. World Neurosurg (2011) 1.62
High-viscosity polymethylmethacrylate cement for endoscopic anterior cranial base reconstruction. J Neurosurg (2010) 1.50
An agarose-based microfluidic platform with a gradient buffer for 3D chemotaxis studies. Biomed Microdevices (2009) 1.48
A mechanical metamaterial made from a DNA hydrogel. Nat Nanotechnol (2012) 1.48
Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc Natl Acad Sci U S A (2011) 1.36
Effects of gel thickness on microscopic indentation measurements of gel modulus. Biophys J (2011) 1.31
Computer-aided tissue engineering: overview, scope and challenges. Biotechnol Appl Biochem (2004) 1.26
Assessing adhesion forces of type I and type IV pili of Xylella fastidiosa bacteria by use of a microfluidic flow chamber. Appl Environ Microbiol (2007) 1.19
Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes. Prostate (2014) 1.14
Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. Ann Neurol (2011) 1.12
Responses of Escherichia coli bacteria to two opposing chemoattractant gradients depend on the chemoreceptor ratio. J Bacteriol (2010) 1.12
Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells. J Neurooncol (2009) 1.11
Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. J Exp Ther Oncol (2009) 1.10
Computer-aided tissue engineering: application to biomimetic modelling and design of tissue scaffolds. Biotechnol Appl Biochem (2004) 1.08
Actinomycetes isolated from lichens: evaluation of their diversity and detection of biosynthetic gene sequences. FEMS Microbiol Ecol (2005) 1.07
Cooperative roles of SDF-1α and EGF gradients on tumor cell migration revealed by a robust 3D microfluidic model. PLoS One (2013) 1.07
Microfluidics for mammalian cell chemotaxis. Ann Biomed Eng (2011) 1.05
Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J (2003) 1.05
Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche. Cancer Res (2013) 1.03
Zero-profile Anchored Spacer Reduces Rate of Dysphagia Compared With ACDF With Anterior Plating. J Spinal Disord Tech (2015) 1.01
Toward single cell traction microscopy within 3D collagen matrices. Exp Cell Res (2013) 1.01
Results and risk factors for recurrence following single-level tubular lumbar microdiscectomy. J Neurosurg Spine (2010) 0.99
Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas. Neurosurg Focus (2011) 0.96
New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurg Focus (2008) 0.95
Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series. Neurosurg Clin N Am (2012) 0.94
Long-term expansion of adult human brain subventricular zone precursors. Neurosurgery (2008) 0.92
The duality of epidermal growth factor receptor (EGFR) signaling and neural stem cell phenotype: cell enhancer or cell transformer? Curr Stem Cell Res Ther (2006) 0.91
Glioblastoma stem-like cells-biology and therapeutic implications. Cancers (Basel) (2011) 0.91
Understanding the role of tumor stem cells in glioblastoma multiforme: a review article. J Neurooncol (2010) 0.89
Cooperative roles of biological flow and surface topography in guiding sperm migration revealed by a microfluidic model. Lab Chip (2014) 0.88
Different migration patterns of sea urchin and mouse sperm revealed by a microfluidic chemotaxis device. PLoS One (2013) 0.87
Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction. J Neurooncol (2011) 0.86
Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia. PLoS One (2012) 0.86
ZTE imaging with long-T2 suppression. NMR Biomed (2014) 0.85
EGFR signaling is differentially activated in patient-derived glioblastoma stem cells. J Exp Ther Oncol (2010) 0.85
Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma. J Exp Ther Oncol (2012) 0.85
A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses. PLoS One (2013) 0.85
The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network. Neurosurgery (2012) 0.84
Modeling tumor microenvironments in vitro. J Biomech Eng (2014) 0.84
Mapping three-dimensional stress and strain fields within a soft hydrogel using a fluorescence microscope. Biophys J (2012) 0.82
Genomic instability of surgical sample and cancer-initiating cell lines from human glioblastoma. Front Biosci (Landmark Ed) (2012) 0.82
Use of human neural tissue for the generation of progenitors. Neurosurgery (2008) 0.81
Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling. J Neurooncol (2014) 0.80
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study. Brachytherapy (2009) 0.79
Rapid and robust pulmonary proton ZTE imaging in the mouse. NMR Biomed (2014) 0.79
Neural stem cells and glioma stem-like cells respond differently to chemotherapeutic drugs: selectivity at the cellular level. Neurosurgery (2011) 0.79
Direct conversion of human fibroblasts to functional neurons in one step. Neurosurgery (2011) 0.79
Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: from bedside to bench. J Clin Neurosci (2012) 0.79
A contact line pinning based microfluidic platform for modelling physiological flows. Lab Chip (2013) 0.78
Development of a human extracellular matrix for applications related with stem cells and tissue engineering. Stem Cell Rev (2012) 0.78
Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays. Stem Cell Rev (2012) 0.78
An array microhabitat system for high throughput studies of microalgal growth under controlled nutrient gradients. Lab Chip (2015) 0.77
Therapeutic stem cells encapsulated in a synthetic extracellular matrix selectively kill tumor cells, delay tumor growth, and increase survival in a mouse resection model of malignant glioma. Neurosurgery (2012) 0.77
Disease-specific induced pluripotent stem cells. Neurosurgery (2008) 0.77
Notch inhibition via micro-RNA blocks glioma development. Neurosurgery (2012) 0.77
Surfactant-mediated control of colloid pattern assembly and attachment strength in evaporating droplets. Langmuir (2013) 0.77
Industry progress report on neuro-oncology: Biotech update 2013. J Neurooncol (2013) 0.77
A microfluidic platform for profiling biomechanical properties of bacteria. Lab Chip (2014) 0.76
Pineal parenchymal tumor of intermediate differentiation with papillary features: a continuum of primary pineal tumors? J Neurooncol (2010) 0.76
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection. J Cancer Res Ther (2010) 0.76
Dissecting the perivascular stem-cell niche: can we take tumor recurrence down a NOTCH? Neurosurgery (2012) 0.76
Prophylactic plastic surgery closure of neurosurgical scalp incisions reduces the incidence of wound complications in previously-operated patients treated with bevacizumab (Avastin®) and radiation. J Neurooncol (2014) 0.76
Targeting a heterogeneous tumor: the promise of the interleukin-13 receptor α2. Neurosurgery (2014) 0.75
VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma. Neurosurgery (2014) 0.75
Magnetic Resonance Imaging to Identify Glioblastoma Molecular Phenotypes. Neurosurgery (2016) 0.75
EGFR targeted inhibition resistance: compensatory activation of ERBB family members in glioblastoma cancer stem-like cells promotes proliferation. Neurosurgery (2012) 0.75
Stem cell based growth factory delivery to the injured spinal cord. Neurosurgery (2010) 0.75
A New Tool in Defining Disease Progression in Glioblastoma. Neurosurgery (2015) 0.75
Expanding the borders: the evolution of neurosurgical approaches. Neurosurg Focus (2014) 0.75
The only way out is in: a deeper understanding of anti-VEGF therapy escape mechanisms offers possibilities for more effective antiangiogenic treatment. Neurosurgery (2013) 0.75
Stem cell populated implanted trachea. Neurosurgery (2009) 0.75
Getting a neural stem cell from a fibroblast. Neurosurgery (2012) 0.75
Gross Total Resection of Glioblastoma Improves Overall Survival and Progression-Free Survival Compared to Subtotal Resection or Biopsy Alone. Neurosurgery (2016) 0.75
Interstitial infusion of erlotinib in the rodent brain. J Exp Ther Oncol (2009) 0.75
Novel hydrogel application in minimally invasive surgical approaches to spontaneous intracranial hypotension. Report of 2 cases. J Neurosurg (2014) 0.75
Transdifferentiation-Induced Neural Stem Cells for the Treatment of Malignant Gliomas. Neurosurgery (2016) 0.75
Industry progress report on neuro-oncology: a biotech update. J Neurooncol (2013) 0.75
Conservative management of cavernous sinus cavernous hemangioma in pregnancy. J Neurosurg (2014) 0.75
Trials and tribulations of cancer immunotherapy: the dendritic cell vaccine shows promise in a phase I glioblastoma multiforme trial. Neurosurgery (2012) 0.75
Forcing tumor stem cells to an end. Neurosurgery (2010) 0.75
The FIRST Trial: Implications for Neurosurgery. Neurosurgery (2016) 0.75
VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma. Neurosurgery (2014) 0.75
Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme. J Exp Ther Oncol (2011) 0.75
Stem cell migration in a novel model to study pediatric brain tumors. Neurosurgery (2008) 0.75
Resetting the stem cell clock: impact of the systemic milieu on oligodendrocyte precursor cell differentiation and remyelination. Neurosurgery (2012) 0.75
Neural stem cells: targeting glioma in 3-dimensions. Neurosurgery (2010) 0.75
Repurposing mebendazole for the treatment of medulloblastoma. Neurosurgery (2015) 0.75
Brain tumor stem cells: will understanding a new paradigm lead to improved therapies? Expert Rev Neurother (2008) 0.75
The intersection between genetic engineering and immunotherapy: taking a BiTE out of glioblastoma. Neurosurgery (2013) 0.75
Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model. J Exp Ther Oncol (2012) 0.75
Transdifferentiation Induced Neural Stem Cells for the Treatment of Malignant Gliomas. Neurosurgery (2016) 0.75
Toxin-secreting implantable therapeutic stem cells. Neurosurgery (2015) 0.75